Recently, Tiram et al. validated the role of two genes from signature, thrombospondin-1 (TSP-1) and epidermal growth factor receptor (EGFR), as regulators of glioblastoma dormancy and explored their therapeutic potential in glioblastoma treatment [44]. Here, EGFR is linked to glioblastoma.